Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

25.00USD
14 Nov 2018
Change (% chg)

$-2.69 (-9.73%)
Prev Close
$27.70
Open
$27.96
Day's High
$28.98
Day's Low
$24.95
Volume
184,215
Avg. Vol
--
52-wk High
$35.55
52-wk Low
$21.67

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -1.193
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 4 -0.25 -0.21 -0.32 --
Quarter Ending Mar-19 3 -0.27 -0.25 -0.30 --
Year Ending Dec-18 4 -2.74 -1.90 -4.09 --
Year Ending Dec-19 4 -1.29 -1.09 -1.43 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 80.78 29.53
P/E High - Last 5 Yrs. -- 271.55 46.39
P/E Low - Last 5 Yrs. -- 85.74 24.60
Beta -- 0.73 0.87
Price to Sales (TTM) -- 222.00 22.95
Price to Book (MRQ) -- 16.68 4.15
Price to Tangible Book (MRQ) 25.02 20.59 13.93
Price to Cash Flow (TTM) -- 49.18 20.94
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.64
Dividend Yield - 5 Year Avg -- 0.22 1.44
Dividend 5 Year Growth Rate -- 3.68 -6.04
Payout Ratio(TTM) -- 7.83 43.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 150.98 6.93
Sales (TTM) vs TTM 1 Yr. Ago -- 62.54 5.64
Sales - 5 Yr. Growth Rate -- 22.39 7.40
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 81.55 31.31
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 20.67 7.72
Capital Spending - 5 Yr. Growth Rate -- 34.65 8.04

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.40 2.57
Current Ratio (MRQ) 9.78 6.54 3.54
LT Debt to Equity (MRQ) 0.00 18.54 11.13
Total Debt to Equity (MRQ) 0.00 24.12 15.47
Interest Coverage (TTM) -- -171.25 40.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.20 54.22
Gross Margin - 5 Yr. Avg. -- 47.69 52.88
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -158.11 15.99
Operating Margin (TTM) -- -1,802.66 -15.93
Operating Margin - 5 Yr. Avg. -- -171.35 11.25
Pre-Tax Margin (TTM) -- -1,733.97 -14.34
Pre-Tax Margin - 5 Yr. Avg. -- -174.09 11.56
Net Profit Margin (TTM) -- -1,729.64 -17.68
Net Profit Margin - 5 Yr. Avg. -- -174.34 7.82
Effective Tax Rate (TTM) -- 14.44 21.42
Effective Tax Rate - 5 Yr. Avg. -- 19.47 24.42

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,905,447 736,529,395
Net Income/Employee (TTM) -- -3,414,892 85,218,451
Receivable Turnover (TTM) -- 8.44 5.31
Inventory Turnover (TTM) -- 2.76 4.11
Asset Turnover (TTM) -- 0.47 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.62 10.32
Return on Assets - 5 Yr. Avg. -- 2.63 10.91
Return on Investment (TTM) -- -0.24 13.00
Return on Investment - 5 Yr. Avg. -- 2.50 14.00
Return on Equity (TTM) -- -3.00 14.69
Return on Equity - 5 Yr. Avg. -- -1.47 15.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Allogene Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.07 10.52 89 91
13 Week -- -- -- 95
26 Week -- -- -- 91
52 Week -- -- -- 98
YTD -- -- -- 92
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 19.62%
# of Holders: 1
Total Shares Held: 23,135,061
3 Mo. Net Change: 23,135,061
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.